Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.

Brambilla F, Bellodi L, Perna G, Arancio C, Bertani A.

Biol Psychiatry. 1997 Nov 15;42(10):889-97.

PMID:
9359974
[PubMed - indexed for MEDLINE]
2.

Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorder.

Brambilla F, Bellodi L, Perna G, Arancio C, Bertani A.

Psychiatry Res. 1998 Dec 14;81(3):293-9.

PMID:
9925180
[PubMed - indexed for MEDLINE]
3.

Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation.

Brambilla F, Perna G, Bussi R, Bellodi L.

Psychoneuroendocrinology. 2000 Apr;25(3):301-10.

PMID:
10737700
[PubMed - indexed for MEDLINE]
4.

Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation.

Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F.

Psychiatry Res. 1997 Mar 24;69(2-3):155-62.

PMID:
9109183
[PubMed - indexed for MEDLINE]
5.

Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach.

Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D.

Psychoneuroendocrinology. 2001 May;26(4):393-409.

PMID:
11259859
[PubMed - indexed for MEDLINE]
6.

Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.

McPherson H, Walsh A, Silverstone T.

J Affect Disord. 2003 Sep;76(1-3):121-5.

PMID:
12943941
[PubMed - indexed for MEDLINE]
7.

Growth hormone response to apomorphine in obsessive-compulsive disorder.

Pitchot W, Hansenne M, Moreno AG, Ansseau M.

J Psychiatry Neurosci. 1996 Nov;21(5):343-5.

PMID:
8973055
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: relationship to somatomedin C levels and dexamethasone suppressibility of cortisol.

Lesch KP, Laux G, Erb A, Pfüller H, Beckmann H.

Psychoneuroendocrinology. 1988;13(3):255-63.

PMID:
3136488
[PubMed - indexed for MEDLINE]
9.

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.

Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC.

Metabolism. 2002 Oct;51(10):1363-9.

PMID:
12370860
[PubMed - indexed for MEDLINE]
10.

TRH stimulation test in obsessive-compulsive patients.

Aizenberg D, Hermesh H, Gil-ad I, Munitz H, Tyano S, Laron Z, Weizman A.

Psychiatry Res. 1991 Jul;38(1):21-6.

PMID:
1946831
[PubMed - indexed for MEDLINE]
11.

The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.

Meltzer HY, Lee MA, Jayathilake K.

Neuropsychopharmacology. 2001 Mar;24(3):278-90.

PMID:
11166518
[PubMed - indexed for MEDLINE]
Free Article
12.

Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.

Budde H, Zimmermann US, Steffin B, Rommelspacher H, Schmidt LG, Smolka MN.

Alcohol Clin Exp Res. 2007 Jan;31(1):100-3.

PMID:
17207107
[PubMed - indexed for MEDLINE]
13.

Growth hormone response to growth hormone-releasing hormone and clonidine in depression.

Gann H, Riemann D, Stoll S, Berger M, Müller WE.

Biol Psychiatry. 1995 Sep 1;38(5):325-9.

PMID:
7495927
[PubMed - indexed for MEDLINE]
14.

Induction of tolerance of dopaminergic responses in man.

Lal S, Thavundayil JX, Ng Ying Kin NM, Dai X, Schwartz G, Montoya A.

J Neural Transm. 2008 Aug;115(8):1189-98. doi: 10.1007/s00702-008-0068-x. Epub 2008 May 28.

PMID:
18506387
[PubMed - indexed for MEDLINE]
15.

A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.

Llau ME, Durrieu G, Tran MA, Senard JM, Rascol O, Montastruc JL.

Clin Neuropharmacol. 1996 Oct;19(5):420-7.

PMID:
8889285
[PubMed - indexed for MEDLINE]
16.

Multihormonal responses to apomorphine in mental illness.

Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP.

Psychoneuroendocrinology. 1995;20(4):365-75.

PMID:
8532820
[PubMed - indexed for MEDLINE]
17.

Noradrenergic and dopaminergic interrelation in schizophrenia.

Brambilla F, Marini S, Saito A, Fassone G, Picardi A, Nerozzi D, Pancheri P.

Psychiatry Res. 1994 Sep;53(3):231-42.

PMID:
7870845
[PubMed - indexed for MEDLINE]
18.

Neuroendocrine responses to levodopa in multiple system atrophy (MSA).

Kimber J, Watson L, Mathias CJ.

Mov Disord. 1999 Nov;14(6):981-7.

PMID:
10584673
[PubMed - indexed for MEDLINE]
19.

Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormone.

Fainstein Day P, Fagin JA, Vaglio RM, Litwak LE, Picasso MF, Gutman RA.

Horm Metab Res. 1998 Dec;30(12):737-42.

PMID:
9930632
[PubMed - indexed for MEDLINE]
20.

Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.

Cecconi E, Bogazzi F, Cetani F, Grasso L, Marcocci C, Genovesi M, Procopio M, Gasperi M, Pinchera A, Ghigo E, Martino E.

Clin Endocrinol (Oxf). 2003 Nov;59(5):604-6.

PMID:
14616884
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk